ShockWave Medical, Inc. / Fundamentals
Income statement
- Net revenue
€676.08M - Cost of goods sold
€87.97M - Gross profit
€588.11M - SG&A expenses
€308.29M - R&D expenses
€139.98M - EBITDA
€161.41M - D&A
€10.09M - EBIT
€139.84M - Interest expenses
€7.90M - EBT
€157.48M - Tax expenses
€17.20M - Net income
€140.28M
Cash flow statement
- Net deferred tax
€2.36M - Non-cash items
-€4.92M - Changes in working capital
-€39.65M - Operating cash flow
€169.82M - Capex
€27.28M - Other investing cash flow
-€60.10M - Net investing cash flow
-€614.64M - Total cash dividends paid
€0.00 - Issuance of common stock
€7.90M - Debt repayment
€0.00 - Other financing cash flow
€447.88M - Net financing cash flow
€447.88M - Foreign exchange effects
-€2.72M - Net change in cash
€290.86K - Cash at end of period
€242.86M - Free cash flow
€197.11M
Balance sheet
- Cash and cash equivalents
€241.68M - Cash and short-term investments
€883.08M - Total receivables
€106.77M - Inventory
€95.42M - Other current assets
€8.98M - Total current assets
€1.09B - Property, plant & equipment
€97.48M - Goodwill
€33.95M - Intangible assets
€78.90M - Long-term investments
€2.02M - Other non-current assets
€7.72M - Total non-current assets
€316.08M - Total assets
€1.41B - Accounts payable
€8.45M - Short-term debt
€3.13M - Other current liabilities
€59.46M - Total current liabilities
€79.22M - Long-term debt
€663.36M - Deferred tax liabilities
€3.10M - Other non-current liabilities
€9.12M - Total non-current liabilities
€686.11M - Total liabilities
€765.33M - Common stock
€32.60K - Retained earnings
€142.27M - Other equity
-€93.52K - Total equity
€645.01M - Total liabilities and shareholders' equity
€1.41B
Company information
- Market capitalization
€10.72B - Employees
1.5K - Enterprise Value
€13.06B
Company ratios
- Gross margin
-
87.0% Much better than peer group: 38.4% - EBITDA margin
-
23.9% Much better than peer group: -327.0% - EBIT margin
-
20.7% Much better than peer group: -355.9% - EBT margin
-
23.3% Much better than peer group: -354,199.8% - Net margin
-
20.7% Much better than peer group: -344.5% - ROE
-
21.7% Much better than peer group: -43.0% - ROA
-
9.9% Better than peer group: -8.4% - Asset turnover
-
47.9% Much worse than peer group: 72.3% - FCF margin
-
21.1% Much better than peer group: -332.1% - FCF yield
1.3% - Efficiency ratio
76.1% - Net sales per employee
-
€460.54K - Net income per employee
-
€95.56K